Eli Lilly and Co (LLY)
750.77
+4.03
(+0.54%)
USD |
NYSE |
Apr 17, 16:00
753.90
+3.13
(+0.42%)
Pre-Market: 08:10
Eli Lilly Cash from Operations (TTM): 4.240B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 4.240B |
September 30, 2023 | 6.215B |
June 30, 2023 | 6.242B |
March 31, 2023 | 6.793B |
December 31, 2022 | 7.586B |
September 30, 2022 | 8.185B |
June 30, 2022 | 7.599B |
March 31, 2022 | 8.192B |
December 31, 2021 | 7.366B |
September 30, 2021 | 6.919B |
June 30, 2021 | 7.095B |
March 31, 2021 | 7.815B |
December 31, 2020 | 6.500B |
September 30, 2020 | 6.648B |
June 30, 2020 | 6.352B |
March 31, 2020 | 4.908B |
December 31, 2019 | 4.837B |
September 30, 2019 | 4.322B |
June 30, 2019 | 4.933B |
March 31, 2019 | 5.399B |
December 31, 2018 | 5.524B |
September 30, 2018 | 5.819B |
June 30, 2018 | 5.579B |
March 31, 2018 | 5.712B |
December 31, 2017 | 5.616B |
Date | Value |
---|---|
September 30, 2017 | 5.879B |
June 30, 2017 | 5.659B |
March 31, 2017 | 5.41B |
December 31, 2016 | 4.851B |
September 30, 2016 | 3.841B |
June 30, 2016 | 3.284B |
March 31, 2016 | 2.830B |
December 31, 2015 | 2.965B |
September 30, 2015 | 3.409B |
June 30, 2015 | 3.996B |
March 31, 2015 | 4.101B |
December 31, 2014 | 4.458B |
September 30, 2014 | 4.744B |
June 30, 2014 | 5.045B |
March 31, 2014 | 5.628B |
December 31, 2013 | 5.735B |
September 30, 2013 | 5.610B |
June 30, 2013 | 5.163B |
March 31, 2013 | 4.832B |
December 31, 2012 | 5.305B |
September 30, 2012 | 5.648B |
June 30, 2012 | 6.177B |
March 31, 2012 | 6.911B |
December 31, 2011 | 7.234B |
September 30, 2011 | 7.518B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
4.240B
Minimum
Dec 2023
8.192B
Maximum
Mar 2022
6.460B
Average
6.648B
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
Amgen Inc | 8.471B |
Madrigal Pharmaceuticals Inc | -324.23M |
Vertex Pharmaceuticals Inc | 3.537B |
Viking Therapeutics Inc | -73.38M |
Moderna Inc | -3.118B |